Sepsistherapie - Warum Change-Management die Letalität der Sepsis senken kann

Herwig Gerlach; Susanne Toussaint

doi:10.1055/s-2006-955856

AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, Inhaltsverzeichnis

Anästhesiol Intensivmed Notfallmed Schmerzther 2006; 41(10): 614-624
DOI: 10.1055/s-2006-955856

Fachwissen: Intensivmedizin

Sepsistherapie - Warum Change-Management die Letalität der Sepsis senken kann

Herwig Gerlach, Susanne Toussaint

Abstract

Volltext

Referenzen

Literaturverzeichnis

1 Murray CJL, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 in Aging Populations. Quelle im Internet: www.hsph.harvard.edu/burdenofdisease/publications/papers/gbd2000.pdf 2001
2 American Cancer Society .Cancer Statistics Slide Set. Quelle im Internet: www.cancer.org/eprise/main/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2002_slides.zip?sitearea=PRO25 2002
3 Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. National Vital Statistics Reports. Quelle im Internet: www.cdc.gov/nchs/data/nvsr/nvsr49/nvsr49_08.pdf 2001
4 Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29 1303-1310
5 Balk RA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000; 16 179-192
6 Bernard G, Vincent JL, Laterre PF. et al. . Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl J Med. 2001; 344 699-709
7 Abraham E, Laterre PF, Garg R, Levy H. et al. . Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005; 353 1332-1341
8 Annane D, Sebille V, Charpentier C. et al. . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288 862-871
9 Rivers E, Nguyen B, Havstad S. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New Engl J Med. 2002; 345 1368-1377
10 van den Berghe G, Wouters P, Weekers F. et al. . Intensive insulin therapy in the critically ill patients. New Engl J Med. 2002; 345 1359-1367
11 Dellinger RP, Carlet JM, Masur H, Gerlach H. et al. . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30 536-555
12 Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989; 95 2S-4S
13 Schubert HJ. Konzepte und Methoden der Steuerung von Veränderungen. Studienbrief der Universität Kaiserslautern, BRD 2001
14 Kostopoulou O, Wildman M. Sources of variability in uncertain medical medical decisions in the ICU: A process training study. Qual Saf Health Care. 2004; 13 272-280
15 Detre KM, Wright E, Murphy ML, Takaro T. Observer agreement in evaluating coronary angiograms. Circulation. 1975; 52 979-986
16 Herrman JP, Azar A, Umans VA, Boersma E, von Es GA, Serruys PW. Inter- and intra-observer variability in the qualitative categorization of coronary angiograms. Int J Card Imaging. 1996; 12 21-30
17 Lee R, MacFarlane T, O'Brien K. Consistency of orthodontic treatment planning decisions. Clin Orthod Res. 1999; 2 79-84
18 Reason J. Human Error. Cambridge, England & New York: Cambridge University Press 1990
19 Reason J. Human error: models and management. BMJ. 2000; 320 768-770
20 Bogner MSW. Human Error in Medicine. Hillsdale, NJ: Lawrence Erlbaum Associates 1994
21 Ferguson ND, Frutos-Vivar F, Esteban A. et al. . Mechanical International Study Group. Airway pressures, tidal volumes, and mortality in patients with acute respiratory distress syndrome. Crit Care Med. 2005; 33 21-30
22 Clemmer TP, Spuhler VJ, Berwick DM, Nolan TW. Cooperation: the foundation of improvement. Ann Intern Med. 1998; 128 1004-1009
23 Clemmer TP, Spuhler VJ. Developing and gaining acceptance for patient care protocols. New Horiz. 1998; 6 12-19
24 Clemmer TP. The use of practice guidelines and protocols. Proceedings of the 27th Annual SCCM Educational and Scientific Symposium. 1998; 292-295
25 GRADE Working Group . Grading quality of evidence and strength of recommendations. BMJ. 2004; 328 1490-1498
26 Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005; 31 243-248
27 Deming WE, Shewhart WA. Review of the International Statistical Institute. 1968; 36 372-375
28 Brock W, Nolan K, Nolan T. Pragmatic science: Accelerating the improvement of critical care. New Horizons. 1998; 6 61-68
29 Langley GL. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. San Francisco: Jossey-Bass 1996
30 ACCP/SCCM Consensus Conference Committee . Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20 864-74
31 Brunkhorst FM, Engel C, Bone H-G. et al. . Epidemiology of severe sepsis an septic shock in Germany - Results from the German Prevalence Study. Infection. 2005; 33 49